Using Mobile Technology to Enhance Psychotherapy for Treatment of Schizophrenia: A Feasibility Study

Chambliss, Catherine; Kontostathis, April

doi:10.11159/vwhci.2014.002

Cited by 2 publications

(3 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Such a slow uptake of mHealth in schizophrenia might in part be due to assumptions that attend the illness, stigmatizing or otherwise, that include concerns about cognitive capacity, symptoms such as delusions, and poverty, and their implications for technology use. Such assumptions are increasingly being contrasted with findings that over 80% of individuals with schizophrenia and other psychoses routinely use cellphone technology without difficulty [9], with a majority expressing an interest in mHealth interventions [10]. Specific areas of interest for applications include reminders regarding medications, check-ins with practitioners, reminders about appointments, and psychoeducation [11,12].…”

Section: Introductionmentioning

confidence: 99%

“…With respect to the academic literature, a recent review identified 11 studies of schizophrenia-specific mHealth applications [15], with our identifying 4 papers published since [16–19]. These studies, and the broader literature that includes web-based platforms, suggest that the range of ehealth and mHealth approaches that include functions such as reminders, self-assessments, behavioural prompts, and in some instances cognitive remediation, are feasible with this population and do not result in any noted risks [10,15,19–21]. Feasibility studies form the bulk of this small body of literature.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Feasibility and outcomes of a multi-function mobile health approach for the schizophrenia spectrum: App4Independence (A4i)

et al. 2019

View full text Add to dashboard Cite

Relative to the large investments in mobile health (mHealth) strategies for mental illnesses such as anxiety and depression, the development of technology to facilitate illness self-management for people with schizophrenia spectrum illnesses is limited. This situation falls out of step with the opportunity mHealth represents for providing inexpensive and accessible self-care resources and the routine use of mobile technologies by people with schizophrenia. Accordingly, the focus of this study was upon the feasibility of a schizophrenia-focused mobile application: App4Independence (A4i). A4i is a multi-feature app that uses feed, scheduling, and text-based functions co-designed with service users to enhance illness self-management. This study was completed in a large urban Canadian centre and employed pre-post assessments over a 1-month period that examined medication adherence, personal recovery, and psychiatric symptomatology. App use metrics were assessed as was qualitative feedback through semi-structured interview. Findings are reported in line with the World Health Organization mHealth Evidence and Assessment (mERA) checklist. Among the 38 individuals with a primary psychosis who participated, there was no research attrition and classic retention on the app was 52.5%. Significant improvement was observed in some psychiatric symptom domains with small-medium effects. Significant change in recovery engagement and medication adherence were not observed after controlling for multiple comparisons. Those who interacted with the app more frequently were more depressed and had higher hostility and interpersonal sensitivity at baseline. Satisfaction with the app was high and qualitative feedback provided insights regarding feature enhancements. This research suggested that A4i is feasible in terms of outcome and process indicators and is a technology that is ready to move on to clinical trial and validation testing. This study contributes to the small but emergent body of work investigating digital health approaches in severe mental illness populations.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Feasibility and outcomes of a multi-function mobile health approach for the schizophrenia spectrum: App4Independence (A4i)

et al. 2019

View full text Add to dashboard Cite

show abstract

“…A number of pilot studies suggest that schizophrenia-targeted mobile and web-based apps in areas such as cognitive remediation are feasible and do not result in any noted risks [ 23 , 26 ]. Most directly relevant to this proposal is the work of Ben-Zeev and colleagues [ 27 ].…”

Section: Introductionmentioning

confidence: 99%

Examining a Digital Health Approach for Advancing Schizophrenia Illness Self-Management and Provider Engagement: Protocol for a Feasibility Trial

Kidd¹,

McKenzie²,

Wang³

et al. 2021

JMIR Res Protoc

View full text Add to dashboard Cite

Background In schizophrenia spectrum populations, adherence to treatment is poor, community-based supports are limited, and efforts to foster illness self-management have had limited success. These challenges contribute to frequent, lengthy, and costly hospital readmissions and poor functional outcomes. Digital health strategies, in turn, hold considerable promise in the effort to address these problems. Objective This feasibility trial will examine a digital health platform called App4Independence (A4i), which was designed to enhance illness self-management and treatment engagement for individuals with schizophrenia. Methods Feasibility metrics in this single-blind, randomized trial include study recruitment and retention, rate of technology use, safety, and utility in clinical interactions. Other outcome metrics include symptomatology, treatment adherence, patient-provider alliance, and quality of life. In this trial, 160 study participants with schizophrenia spectrum diagnoses will be randomized to either treatment or control conditions, with pretest-posttest outcomes measured over a 6-month period. Results This study was funded by the Canadian Institutes of Health Research in January 2020 and received Institutional Review Board approval on August 13, 2020. This study plans to begin recruiting in January 2021 and will be completed within 3 years. Data collection is projected to begin in January 2021. Conclusions This research will provide critical information for the development of this new technology in the larger effort to address a key problem in the schizophrenia field—how to leverage technology to enhance illness self-management and care engagement in resource-limited service contexts. International Registered Report Identifier (IRRID) PRR1-10.2196/24736

show abstract

Using Mobile Technology to Enhance Psychotherapy for Treatment of Schizophrenia: A Feasibility Study

Cited by 2 publications

References 24 publications

Feasibility and outcomes of a multi-function mobile health approach for the schizophrenia spectrum: App4Independence (A4i)

Feasibility and outcomes of a multi-function mobile health approach for the schizophrenia spectrum: App4Independence (A4i)

Examining a Digital Health Approach for Advancing Schizophrenia Illness Self-Management and Provider Engagement: Protocol for a Feasibility Trial

Contact Info

Product

Resources

About